Epidemiology, disease burden and treatment patterns for primary IgA nephropathy patients: A real-world data study in The Netherlands

  Back
Epidemiology, disease burden and treatment patterns for primary IgA nephropathy patients: A real-world data study in The Netherlands
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/2a11c22a5f82a212a0495fa2126b8d03.pdf
Sasikiran
Nunna
9
Yuelin Zhuang zhuangyl@zjotsuka.com Otsuka Pharmaceuticals Shanghai China
Thom Lysen thom.lysen@pharmo.com PHARMO Institute for Drug Outcomes Research HEOR Utrecht Netherlands
Alice Eberhardt aeberhardt@otsuka.de Otsuka Pharma GmbH Global Value and Real World Evidence Frankfurt Germany
Sasikiran Nunna sasikiran.nunna@otsuka-us.com Otsuka Pharmaceutical Development & Commercialization, Inc. Global Value and Real World Evidence Princeton United States
Hema Gandhi hema.gandhi-cw@otsuka-us.com Otsuka Pharmaceutical Development & Commercialization, Inc. Global Value and Real World Evidence Princeton United States
Naomi Reines naomi.reimes@pharmo.com PHARMO Institute for Drug Outcomes Research HEOR Utrecht Netherlands
Brenda Baak brenda.baak@pharmo.com PHARMO Institute for Drug Outcomes Research HEOR Utrecht Netherlands
Lisa Smitts lisa.smits@pharmo.nl PHARMO Institute for Drug Outcomes Research HEOR Utrecht Netherlands
Jetty Overbeek jetty.overbeek@pharmo.com PHARMO Institute for Drug Outcomes Research HEOR Utrecht Netherlands
Raphaël Duivenvoorden raphael.duivenvoorden@radboudumc.nl Radboud University Medical Center Department of Nephrology Nijmegen Netherlands